Literature DB >> 34232520

Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019-The pilot study.

Petra Bistrovic1,2, Marko Lucijanic2,3,4.   

Abstract

Entities:  

Year:  2021        PMID： 34232520     DOI： 10.1002/jmv.27177

Source DB:  PubMed          Journal:  J Med Virol        ISSN： 0146-6615            Impact factor:   2.327


× No keyword cloud information.
  8 in total

1.  Bradyarrhythmia After Remdesivir Administration in SARS-CoV-2: A Review of Literature and Meta-Analysis of Observational Studies in Epidemiology.

Authors:  Safa Al-Jammali; Rana Al-Zakhari; Nicholas Sheets; Arun Mahtani; Veronika Stefanishina; Nidal Isber
Journal:  Cardiol Res       Date:  2022-05-10

Review 2.  Scoping insight on antiviral drugs against COVID-19.

Authors:  Ahmed S Ali; Ibrahim M Ibrahim; Abdulhadi S Burzangi; Ragia H Ghoneim; Hanin S Aljohani; Hamoud A Alsamhan; Jehan Barakat
Journal:  Arab J Chem       Date:  2021-08-16       Impact factor: 5.165

3.  The potential of remdesivir to affect function, metabolism and proliferation of cardiac and kidney cells in vitro.

Authors:  Katja Merches; Leonie Breunig; Julia Fender; Theresa Brand; Vanessa Bätz; Svenja Idel; Laxmikanth Kollipara; Yvonne Reinders; Albert Sickmann; Angela Mally; Kristina Lorenz
Journal:  Arch Toxicol       Date:  2022-05-17       Impact factor: 6.168

4.  Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis.

Authors:  Petra Bistrovic; Sime Manola; Ivan Papic; Ana Jordan; Maja Ortner Hadziabdic; Marko Lucijanic
Journal:  Am J Emerg Med       Date:  2022-05-10       Impact factor: 4.093

5.  Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report.

Authors:  Katarzyna Guziejko; Jaroslaw Talalaj; Monika Chorazy; Monika Groth; Anna Moniuszko-Malinowska
Journal:  Infection       Date:  2022-06-14       Impact factor: 7.455

Review 6.  Potential Cardiotoxic Effects of Remdesivir on Cardiovascular System: A Literature Review.

Authors:  Maryam Nabati; Homa Parsaee
Journal:  Cardiovasc Toxicol       Date:  2021-10-13       Impact factor: 2.755

7.  Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis.

Authors:  Marko Lucijanic; Tomislav Cikara; Petra Bistrovic; Ivan Papic; Maja Ortner Hadziabdic; Nikolina Busic; Marina Lackovic; Natalia Cesar; Valentina Koscak; Josko Mitrovic; Bruno Barsic; Tomo Lucijanic
Journal:  J Infect       Date:  2022-05-02       Impact factor: 38.637

Review 8.  Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19.

Authors:  Jialu Huang; Yubo Ding; Jingwei Yao; Minghui Zhang; Yu Zhang; Zhuoyi Xie; Jianhong Zuo
Journal:  Vaccines (Basel)       Date:  2022-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.